ArticleNature biomedical engineering2026
A pre-trained large generative model for translating single-cell transcriptomes to proteomes.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Multi-omics-driven precision medicine.iMeta · 2026Review
- Advancing bioinformatics with language models: components, applications, and perspectives.Briefings in bioinformatics · 2026Review
- T2Pdecoder enables protein-centric analyses from transcriptomic data.Nature communications · 2026Article
- CAPTAIN: a multimodal foundation model pretrained on co-assayed single-cell RNA and protein.Nature communications · 2026Article
- Machine learning predictions surpass individual mRNAs as a proxy of single-cell protein expression.Genome biology · 2026Article
- A sequence knowledge-guided deep learning method for single-cell multi-omics translation.Genome biology · 2026Article
- Single-Cell and Spatial Omics: Methods and Applications.MedComm · 2026Review
- Large-scale multi-omic biosequence transformers for modeling protein-nucleic acid interactions.PloS one · 2026Article
- Cross-level Cross-Scale Inference and Imputation of Single-cell Spatial Proteomics.Research square · 2025Article
- Large-Scale Multi-omic Biosequence Transformers for Modeling Protein-Nucleic Acid Interactions.ArXiv · 2025Article
- CSI-GEP: A GPU-based unsupervised machine learning approach for recovering gene expression programs in atlas-scale single-cell RNA-seq data.Cell genomics · 2025Article
- AI-empowered perturbation proteomics for complex biological systems.Cell genomics · 2024Article
- Imputing abundance of over 2,500 surface proteins from single-cell transcriptomes with context-agnostic zero-shot deep ensembles.Cell systems · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Measuring protein abundance at the single-cell level can facilitate a high-resolution understanding of biological mechanisms in cellular processes and disease progression. However, current single-cell proteomic technologies face challenges such as limited coverage, constrained throughput and sensitivity, batch effects, high costs and stringent experimental operations. Inspired by the translation procedure in both natural language processing and the genetic central dogma, we propose a pre-trained, large generative model named single-cell translator (scTranslator). scTranslator can generate multi-omics data by inferring the missing single-cell proteome based on the transcriptome. Through systematic benchmarking and validation on independent datasets, we have confirmed the accuracy, stability and flexibility of scTranslator across various profiling techniques (for example, CITE-seq, spatial CITE-seq, REAP-seq, NEAT-seq), cell types (for example, monocytes, macrophages, T cells, B cells), tissues (for example, blood, lung, brain) and a wide range of disease contexts, including infectious, metabolic and oncologic conditions. Furthermore, scTranslator shows its superiority in assisting various downstream analyses and applications, including gene/protein interaction inference, perturbation prediction, cell clustering, batch correction and cell origin recognition in pan-cancer data.
Indexed as
Identifiers
41193888What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.